Cromolyn sodium, five to six years later

Annals of Allergy
|August 1, 1977
PubMed

Insights

Cromolyn effectively managed chronic asthma in children, reducing reliance on bronchodilators. However, its success in decreasing steroid dependency was limited, especially in steroid-dependent cases.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Difficult-to-treat asthma in children presents significant management challenges.
  • Long-term prophylactic strategies are crucial for chronic asthma control.

Purpose of the Study:

  • To evaluate the long-term efficacy of cromolyn sodium prophylaxis in children with chronic asthma.
  • To assess the potential for decreasing dependency on bronchodilators and corticosteroids.

Main Methods:

  • Double-blind, crossover studies followed by a five-to-six-year open trial of cromolyn prophylaxis.
  • Evaluation included clinical assessments, bronchodilator/corticosteroid use, peak expiratory flow rates, and exercise tolerance.
  • IgE specific RAST was used to identify extrinsic allergic components.

Main Results:

  • Cromolyn prophylaxis was effective for many children with chronic asthma.
  • A significant number of patients remained dependent on bronchodilators or corticosteroids.
  • Improvement in exercise tolerance was observed in some patients, but steroid reduction was challenging.

Conclusions:

  • Cromolyn sodium serves as an effective prophylactic agent for pediatric chronic asthma.
  • Reducing or discontinuing steroid use in steroid-dependent asthmatic children proved difficult with cromolyn.
  • Further research is needed to optimize long-term asthma management strategies in children.

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...